ULTRA – CBD:THC 20:1

$90.00

Anresco Labs COA** FMCULT0720

Ratio CBD:THC: 20:1
Dosage: 20mg CBD and 1mg THC (each capsule)
Packaging: Pill Cards of 30 capsules, each that contain a total of 630mg of combined cannabinoids.

Ideal for: Patients primarily seeking increased physical comfort and virtually no psychoactive experience while still maintaining the benefits of the CBD:THC entourage effect.

* Product prices include all taxes, fees & delivery

Category:

Description

ULTRA – CBD:THC 20:1

Widely recommended for: those who wish to avoid any potential side effects from THC*, while still benefiting from the entourage effect** and easing symptoms of psychosis, anxiety, depression, muscle pain, some types of chronic pain, PTSD, reducing inflammation, easing cravings, and creating a sense of wellbeing. There is only a very small amount of THC in Ultra as it is predominantly CBD at 20mgs to 1mg THC.  

*potential side effects of THC include euphoria, increased appetite, increased nervousness, paranoia, and somnolence but are rarely reported in low doses, as recommended by a physician. It is always recommended to start with a low dose and go slow to avoid unwanted effects.

**entourage effect: getting the benefits of the whole plant, synergistically, not merely an isolate. This product contains a small amount of THC naturally, which maximizes the benefits of CBD in the body and brain without causing a “high feeling” in most people.

OUR CAPSULES (CAPS) each contain a specific, consistent cannabinoid dosage including a proprietary balance of natural terpene extracts. Capsules are then packaged, labeled and batch tested for accuracy, potency and potential contaminants. Delivery consists of a child-resistant zip bag containing a pharmacy style blister Pill Card, including patient-specific labels.

Whether you are a doctor, caregiver, care facility director or patient, you can be confident Farmacann products always meet or exceed the manufacturing, testing and regulatory requirements of the State of California, Medical Professionals and Licensed Care Facilities and every batch of each product receives a COA** from Anresco Laboratories in San Francisco, an industry leader since 1943, ISO 17025 accredited, FDA registered, and ELAP certified.

** A Certificate of Analysis, or COA, is a document issued by a third-party, independent testing laboratory that confirms a product meets its specification, including quantity of cannabinoids and terpenes found in each product as well as confirming that each product does not contain harmful heavy metals, pesticides, solvents, and pathogens.

Sign up for the Farmacann Newsletter

Sign up to know about all of our educational events, learn about relevant medical cannabis news and the latest research that impacts our community.

We don’t spam! Read our privacy policy for more info.